Cargando…
Liposarcoma: Advances in Cellular and Molecular Genetics Alterations and Corresponding Clinical Treatment
Liposarcoma is a malignant tumor of mesenchymal origin with significant tissue diversity. It is composed of adipocytes with different degrees of differentiation and different degrees of heteromorphosis. It is not sensitive to traditional radiotherapy and chemotherapy and has a poor prognosis. In rec...
Autores principales: | Yang, Lingge, Chen, Shiqi, Luo, Peng, Yan, Wangjun, Wang, Chunmeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6930414/ https://www.ncbi.nlm.nih.gov/pubmed/31892977 http://dx.doi.org/10.7150/jca.36380 |
Ejemplares similares
-
Prognostic significance of pretreatment lymphocyte/monocyte ratio in retroperitoneal liposarcoma patients after radical resection
por: Luo, Peng, et al.
Publicado: (2018) -
CCNDBP1, a Prognostic Marker Regulated by DNA Methylation, Inhibits Aggressive Behavior in Dedifferentiated Liposarcoma via Repressing Epithelial Mesenchymal Transition
por: Yang, Lingge, et al.
Publicado: (2021) -
Retroperitoneal dedifferentiated liposarcoma: Analysis of 61 cases from a large institution
por: Luo, Peng, et al.
Publicado: (2018) -
Prognostic analysis of surgically treated clear cell sarcoma: an analysis of a rare tumor from a single center
por: Chen, Shiqi, et al.
Publicado: (2019) -
Apatinib mesylate tablet in the treatment of advanced malignant melanoma
por: Yang, Lingge, et al.
Publicado: (2018)